Stay updated on Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Sign up to get notified when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.

Latest updates to the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page
- Check2 days agoChange DetectedUpdate of the ClinicalTrials.gov page revision indicator from “v3.5.2” to “v3.5.3,” reflecting a platform/version change without altering the study’s recorded content.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedA new revision entry v3.5.0 was added to the record history, and v3.4.3 was removed.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed from the study record history.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision entry v3.4.2 was added to the record history, and the entry for v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedVersion v3.4.1 was added and v3.4.0 was removed in the record history. There are no visible changes to the study data or status in this view.SummaryDifference0.1%

Stay in the know with updates to Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.